# BioPhero

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biophero-aps

- Industry: Biotechnology
- Headquarters: Copenhagen, Denmark
- Website: www.biophero.com
- Total disclosed funding: $20M
- Latest round: Series A (Mar 8, 2021)
- Investors on record: 5

## About

Based in Denmark, BioPhero ApS is a biotechnology company specializing in developing innovative pheromone products for sustainable pest management in agriculture.BioPhero ApS, founded in 2016, operates in the biotechnology sector, focusing on pheromone-based solutions for pest control. The company is headquartered in Copenhagen, Denmark. Carina Holkenbrink, the founder, has a history of entrepreneurship in the biotech field. In June 2022, FMC Corporation agreed to acquire BioPhero for USD 200 mn as part of a Trade Sale, which is expected to close by September 2022, after regulatory approvals. This acquisition marks a significant strategic move for FMC Corporation to enhance its product offerings.BioPhero specializes in innovative pheromone products designed to enhance pest management strategies in agriculture, emphasizing sustainability and productivity. Their core offerings leverage sex pheromones to disrupt mating patterns among insect populations, effectively preventing the emergence of new generations of pests. This species-specific approach minimizes the impact on beneficial insects, such as bees, while addressing pest control in a targeted manner. BioPhero's products cater to a diverse range of crops and climatic conditions globally, focusing on high-value specialty crops like fruits and vegetables, as well as large row crops, and are marketed across various geographical regions, including North America, South America, Europe, and parts of Asia.In the most recent year, BioPhero reported a revenue of USD 0.00, with an EBITDA of USD -3,052,481.60 in 2022. The company generates revenue through the sale of its pheromone products to agricultural growers, primarily through B2B transactions with distributors and wholesalers. Pricing structures reflect the volume and type of application, accommodating various agricultural markets for tailored pest management solutions.The recent acquisition by FMC Corporation will support BioPhero's growth strategy, as it integrates into a larger platform focused on enhancing pest management solutions. The deal, finalized by September 2022, aims to leverage FMC's extensive distribution networks to expand BioPhero's market presence. Future initiatives may include the development of new pheromone products tailored to emerging agricultural pests and expansion into new global markets, particularly in Asia and South America, in response to growing agricultural demands.

## Funding rounds

- Series A, Mar 8, 2021, $17M — Novo Holdings, DCVC, Syngenta Ventures, FMC
- Seed, Sep 17, 2018, $3.5M — Novo Holdings, SDTI, Syngenta Ventures

## Investors

- Novo Holdings — Seed, Series A
- SDTI (https://capitalatlas.ai/funds/sdti) — Seed
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Seed, Series A
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A
- FMC (https://capitalatlas.ai/funds/fmc) — Series A